Chinook Therapeutics, Inc. EPS - Earnings per Share 2015-2023 | KDNY
Chinook Therapeutics, Inc. eps - earnings per share from 2015 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Chinook Therapeutics, Inc. Annual EPS |
| 2022 |
$-2.92 |
| 2021 |
$-2.26 |
| 2020 |
$-6.20 |
| 2019 |
$-25.48 |
| 2018 |
$-6.05 |
| 2017 |
$-6.30 |
| 2016 |
$-7.00 |
| 2015 |
$-4.40 |
| 2014 |
$-265.30 |
| 2013 |
$-279.00 |
| Chinook Therapeutics, Inc. Quarterly EPS |
| 2023-06-30 |
$-0.94 |
| 2023-03-31 |
$-0.85 |
| 2022-12-31 |
$-0.94 |
| 2022-09-30 |
$-0.83 |
| 2022-06-30 |
$-0.61 |
| 2022-03-31 |
$-0.54 |
| 2021-12-31 |
$0.28 |
| 2021-09-30 |
$-0.69 |
| 2021-06-30 |
$-0.97 |
| 2021-03-31 |
$-0.88 |
| 2020-12-31 |
$-1.24 |
| 2020-09-30 |
$-4.50 |
| 2020-06-30 |
$-1.87 |
| 2020-03-31 |
$-1.25 |
| 2019-12-31 |
$-21.57 |
| 2019-09-30 |
$-1.31 |
| 2019-06-30 |
$-1.15 |
| 2019-03-31 |
$-1.45 |
| 2018-12-31 |
$-1.65 |
| 2018-09-30 |
$-1.45 |
| 2018-06-30 |
$-1.55 |
| 2018-03-31 |
$-1.40 |
| 2017-12-31 |
$-1.70 |
| 2017-09-30 |
$-1.65 |
| 2017-06-30 |
$-1.35 |
| 2017-03-31 |
$-1.60 |
| 2016-12-31 |
$-2.20 |
| 2016-09-30 |
$-2.70 |
| 2016-06-30 |
$0.15 |
| 2016-03-31 |
$-2.25 |
| 2015-12-31 |
$197.90 |
| 2015-09-30 |
$0.05 |
| 2015-06-30 |
$-2.50 |
| 2015-03-31 |
$-199.85 |
| 2014-12-31 |
$-1.05 |
| 2014-09-30 |
$-71.20 |
| 2014-06-30 |
$-61.35 |
| 2014-03-31 |
$-131.70 |
